SRPT - Sarepta Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SRPT is currently covered by 25 analysts with an average price target of $78.82. This is a potential upside of $41.22 (109.63%) from yesterday's end of day stock price of $37.6.

Sarepta Therapeutics's activity chart (see below) currently has 662 price targets and 622 ratings on display. The stock rating distribution of SRPT is 79.26% BUY, 14.07% HOLD and 6.67% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.57% with an average time for these price targets to be met of 266.29 days.

Highest price target for SRPT is $230, Lowest price target is $40, average price target is $142.52.

Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 20-May-2025. First documented stock forecast 20-Mar-2013.

Currently out of the existing stock ratings of SRPT, 107 are a BUY (79.26%), 19 are a HOLD (14.07%), 9 are a SELL (6.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$84

$46.4 (123.40%)

$175

11 days ago
(20-May-2025)

9/17 (52.94%)

$44.01 (110.05%)

125

Buy

$50

$12.4 (32.98%)

$217

23 days ago
(08-May-2025)

6/12 (50%)

$13.48 (36.91%)

212

Buy

$125

$87.4 (232.45%)

$183

24 days ago
(07-May-2025)

11/31 (35.48%)

$88.28 (240.41%)

349

Hold

$58

$20.4 (54.26%)

$87

24 days ago
(07-May-2025)

16/51 (31.37%)

$21.28 (57.95%)

337

Buy

$113

$75.4 (200.53%)

$182

24 days ago
(07-May-2025)

17/28 (60.71%)

$76.28 (207.73%)

294

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SRPT (Sarepta Therapeutics) average time for price targets to be met?

On average it took 266.29 days on average for the stock forecasts to be realized with a an average price target met ratio 57.57

Which analyst has the current highest performing score on SRPT (Sarepta Therapeutics) with a proven track record?

DIFEI YANG

Which analyst has the most public recommendations on SRPT (Sarepta Therapeutics)?

Difei Yang has 22 price targets and 20 ratings on SRPT

Which analyst is the currently most bullish on SRPT (Sarepta Therapeutics)?

Mani Foroohar with highest potential upside - $192.4

Which analyst is the currently most reserved on SRPT (Sarepta Therapeutics)?

Steve Brozak with lowest potential downside - -$79.57

Sarepta Therapeutics in the News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of  Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Sarepta and certain of its officers and/or directors have engaged in securities...

Is Sarepta Therapeutics, Inc. (SRPT) The Best Stock That Will Bounce Back?

We recently compiled a list of the 11 Stocks That Will Bounce Back According To Analysts. In this article, we are going to take a look at where Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stands against the other stocks that will bounce back. Major US indexes finished in the green on Wednesday, May 7, after a volatile...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?